Multiple Patents Granted and Pipeline of Ophthalmic Drug Candidates

We are advancing a pipeline of wholly-owned candidates that address a number of diseases with high unmet need from front of eye conditions to back of eye conditions. The lead project is CBT-001 for the treatment of pterygium.